The P.U.M.P. Study Shows:

RETIN-A MICRO® (tretinoin gel) microsphere, 0.04%/0.1% Pump delivers well-tolerated therapy and high patient satisfaction when used in combination with other acne treatment.1

RETIN-A MICRO® Pump shows minimal irritation and low potential for complaints*1

Chart: RETIN-A MICRO Pump shows minimal irritation and low potential for complaints

  • No severe adverse events reported throughout 12-week P.U.M.P. study
  • Minimal irritation across skin types with all Fitzpatrick skin types represented in study
  • Cutaneous irritation was transient and tended to improve from week 3 on

92% study completion rate suggests that RETIN-A MICRO® Pump delivers well-tolerated therapy1, 2

*Reported incidence.
References:
1.Eichenfield LF, Nighland M, Rossi AB, et al; PUMP Study Group. Phase 4 study to assess tretinoin pump for the treatment of facial acne. J Drugs Dermatol. 2008;7(12):1129-1136.
2.Data on file, Ortho Dermatologics.